INSUBCONTINENT EXCLUSIVE:
The pill, called AD109, has been developed by pharmaceutical company Apnimed as a treatment for obstructive sleep apnoea - a condition
characterised by snoring and interrupted breathing at night
This article first appeared/also appeared in Mirror
